Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating two strategies for administering the R21-Matrix M malaria vaccine in Chad during seasonal transmission; recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R21-Matrix M Vaccine (R21-Matrix M)

Snippet

Sponsor: Epicentre | Conditions: Malaria Infection, Malaria Vaccines | Phase 4 | Status: RECRUITING